Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of different concentrations of PHP0101 eye drops in Chinese patients with presbyopia
CTR20253762Phase 2Active
- Sponsor
- Pulekang Pharmaceutical
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pilocarpine in presbyopia, sponsored by Pulekang Pharmaceutical. Started Sep 2025; status: active.
02
Drugs
pilocarpine
03
Conditions
presbyopia
Beyond the preview
Go deeper on CTR20253762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253762.